Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Jan 28 2021
Published Jan 28 2021
4 min read

Press Release Jan 28 2021

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 28, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg".

View Attachment